-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
9 Meters Biopharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2017 to Q1 2023.
- 9 Meters Biopharma, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2023 was -$1.08M, a 8741% decline year-over-year.
- 9 Meters Biopharma, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2023 was -$2.84M, a 10627% decline year-over-year.
- 9 Meters Biopharma, Inc. annual Nonoperating Income (Expense) for 2022 was -$1.75M, a 9907% decline from 2021.
- 9 Meters Biopharma, Inc. annual Nonoperating Income (Expense) for 2021 was -$17.5K, a 97.2% increase from 2020.
- 9 Meters Biopharma, Inc. annual Nonoperating Income (Expense) for 2020 was -$619K, a 58.8% increase from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)